Resource Center
Resource Center
CEO Iain Barton chats about CHAI's COVID-19 response, what he is bringing to the organization, and setting “big, hairy, audacious goals” for the future.
Read moreAgreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.
Read moreBeginning on April 28, 2020, CHAI and Unitaid will begin accepting Expressions of Interest (EOI) and admitting selected partners to the EMAV on a rolling basis through September 30, 2021 (or when maximum volume commitment is delivered).
Read morePreclinical work in mice and primates has demonstrated that a single injection of a new drug developed by UNMC is effective in achieving blood drug levels known to be active against HIV for up to one year.
Read moreClinics targeted at mothers and their infants as way to retain HIV-exposed infants in care until they reach 18 months.
Read moreIn 2018, CHAI and the government of Zimbabwe ran a pilot, designed to assess the feasibility of offering PrEP in the public sector as part of comprehensive HIV prevention services. As part of the pilot, CHAI completed a study, the results of which are now available.
Read moreCHAI is proud of the progress that we have made over the past year to address health issues in low- and middle-income countries. We have not made that progress alone. We work closely with governments, other organizations and community groups, as well as the private sector, to save lives and reduce the burden of...
Read moreOur Senior Director for HIV reflects on World AIDS Day: "Although we have had many successes over the past decade in our work in HIV, it is our failures that keep me up at night and push me to do more."
Read moreThe theme for the 2018 Annual Report is ‘Our Approach in Action’. There are examples in each program section of a time that CHAI’s approach was successfully applied to support our partners toward our mission.
Read moreCHAI is pleased to release the 10th issue of our annual HIV Market Report: The state of HIV treatment, testing, and prevention in low- and middle-income countries. The report provides a detailed look at the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work...
Read more